Long-Term Efficacy of Dupilumab for the Treatment of Prurigo Nodularis: A Case Series
Journal Title: Journal of Dermatology Research - Year 2023, Vol 4, Issue 3
Abstract
Prurigo nodularis is a chronic, pruritic dermatologic condition that results in nodule formation on the skin that is often treatment refractory and can impair quality of life. The underlying biological mechanism of prurigo nodularis formation is not completely understood, however, many affected patients have an underlying atopic diathesis. Existing therapies provide inadequate outcomes. Dupilumab has recently been approved for the treatment of prurigo nodularis, however, long term efficacy beyond one year has yet to be established. Here we present a series of four patients with prurigo nodularis that were successfully treated with dupilumab and maintained efficacy with a range of 26 months to 79 months.
Authors and Affiliations
Edward M Klepper, Maria L Andrzejewski, Amy Rizkallah, Jonathan J Lee, Howard N Robinson
Keywords
Related Articles
- EP ID EP722224
- DOI https://doi.org/10.46889/JDR.2023.4305
- Views 31
- Downloads 0
Immunophenotypes in Atopic Dermatitis
Atopic Dermatitis is a very heterogeneous and complex disease. Recently, the ethnic background has been reported as a determining factor for a better understanding of genetic differences, clinical phenotypes, and immun...
Case Report of Hailey-Hailey Disease Successfully Treated with Topical Roflumilast 0.3% Cream
Hailey-Hailey Disease, also called Benign Familial Pemphigus, is a genetic acantholytic blistering condition that most commonly affects the intertriginous areas. There are many treatments, both on and off label, for the...
Androgenetic Alopecia: A Study on The Efficacy of a Combined Protocol of Blue Light Photobiomodulation and Subcutaneous Infiltrations of Biomimetic Peptides
Androgenetic Alopecia (AGA) is a common condition affecting men and women, characterized by progressive hair follicle miniaturization and consequent hair loss. Blue light Photobiomodulation (PBM) by LED (Light emitting d...
Diffuse Alopecia Areata and Its Trichoscopic Findings Following COVID-19 mRNA-1273 Vaccination: A Case Report
Background: Alopecia Areata (AA) is a common autoimmune disease leading to non-scarring hair loss. Previously, AA had been noted following various vaccinations including influenza virus, hepatitis B virus, herpes zoster...
Stem Cell Therapy in Androgenetic Alopecia: A Review of Dermatology Literature from 2012-2022
Androgenetic alopecia is considered the most frequent form of progressive hair loss. In this disease, an alteration of the hair cycle dynamics leads to progressive miniaturization of the hair follicle and possible baldne...